clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: brisk pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler brisk pharmaceuticals
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 150 mg/1

Manufacturer
Brisk Pharmaceuticals

Identifiers & Regulatory

Product NDC 73614-204
Product ID 73614-204_2de041be-1d37-ee95-e063-6294a90a2091
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216957
Listing Expiration 2026-12-31
Marketing Start 2023-03-10

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73614204
Hyphenated Format 73614-204

Supplemental Identifiers

RxCUI
197518
UNII
T20OQ1YN1W

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number ANDA216957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (73614-204-03)
source: ndc

Packages (1)

73614-204-03 30 CAPSULE in 1 BOTTLE (73614-204-03)

Ingredients (1)

clindamycin hydrochloride (150 mg/1)

Linked Drug Pages (1)

Clindamycin Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2de041be-1d37-ee95-e063-6294a90a2091", "openfda": {"unii": ["T20OQ1YN1W"], "rxcui": ["197518"], "spl_set_id": ["2de041be-1d36-ee95-e063-6294a90a2091"], "manufacturer_name": ["Brisk Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (73614-204-03)", "package_ndc": "73614-204-03", "marketing_start_date": "20250210"}], "brand_name": "Clindamycin Hydrochloride", "product_id": "73614-204_2de041be-1d37-ee95-e063-6294a90a2091", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "73614-204", "generic_name": "Clindamycin Hydrochloride", "labeler_name": "Brisk Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin Hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216957", "marketing_category": "ANDA", "marketing_start_date": "20230310", "listing_expiration_date": "20261231"}